Lisa Helbling is chief financial officer of ImmunoPrecise Antibodies, Ltd (IPA). She has served as a director on the Board since 2017.
Prior to working at IPA, Lisa was chief financial officer of Anchor Ingredients and chief financial officer of TMI Holdings I (TMI). Lisa has 33 years of broad experience in finance, accounting, enterprise risk management, audit and ESOPs. Her industry experience includes hospitality, electric utility, manufacturing, construction, transportation, life insurance and public accounting.
Lisa holds bachelor's degrees in accounting from Moorhead State University and business administration from North Dakota State University in Fargo. She is a certified public accountant and certified internal auditor.